These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37745306)

  • 21. Cellular expansion of MSCs: Shifting the regenerative potential.
    Miclau K; Hambright WS; Huard J; Stoddart MJ; Bahney CS
    Aging Cell; 2023 Jan; 22(1):e13759. PubMed ID: 36536521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional culture conditioned bone marrow MSC secretome accelerates wound healing in a burn injury mouse model.
    Gangadaran P; Oh EJ; Rajendran RL; Oh JM; Kim HM; Kwak S; Chung HY; Lee J; Ahn BC; Hong CM
    Biochem Biophys Res Commun; 2023 Sep; 673():87-95. PubMed ID: 37364390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stromal cells pretreated with proinflammatory cytokines enhance skin wound healing via IL-6-dependent M2 polarization.
    Liu C; Xu Y; Lu Y; Du P; Li X; Wang C; Guo P; Diao L; Lu G
    Stem Cell Res Ther; 2022 Aug; 13(1):414. PubMed ID: 35964139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds-In Vitro Study.
    Kraskiewicz H; Hinc P; Krawczenko A; Bielawska-Pohl A; Paprocka M; Witkowska D; Mohd Isa IL; Pandit A; Klimczak A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.
    Papait A; Ragni E; Cargnoni A; Vertua E; Romele P; Masserdotti A; Perucca Orfei C; Signoroni PB; Magatti M; Silini AR; De Girolamo L; Parolini O
    Front Immunol; 2022; 13():960909. PubMed ID: 36052081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1β-primed mesenchymal stromal cells exert enhanced therapeutic effects to alleviate Chronic Prostatitis/Chronic Pelvic Pain Syndrome through systemic immunity.
    Liu H; Zhu X; Cao X; Chi A; Dai J; Wang Z; Deng C; Zhang M
    Stem Cell Res Ther; 2021 Sep; 12(1):514. PubMed ID: 34563249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boosting the therapeutic potential of cell secretome against osteoarthritis: Comparison of cytokine-based priming strategies.
    Giannasi C; Della Morte E; Cadelano F; Valenza A; Casati S; Dei Cas M; Niada S; Brini AT
    Biomed Pharmacother; 2024 Jan; 170():115970. PubMed ID: 38042116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.
    Gray A; Maguire T; Schloss R; Yarmush ML
    Biotechnol Prog; 2015; 31(4):1058-70. PubMed ID: 25958832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-Conditioned Mesenchymal Stem Cells in Tissue Regeneration Application.
    Yang Y; Lee EH; Yang Z
    Tissue Eng Part B Rev; 2022 Oct; 28(5):966-977. PubMed ID: 34569290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.
    Elshaer SL; Bahram SH; Rajashekar P; Gangaraju R; El-Remessy AB
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
    Trigo CM; Rodrigues JS; Camões SP; Solá S; Miranda JP
    J Adv Res; 2024 May; ():. PubMed ID: 38729561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing.
    Ma D; Kua JE; Lim WK; Lee ST; Chua AW
    Cytotherapy; 2015 Aug; 17(8):1036-51. PubMed ID: 25981558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3-gallate augments therapeutic effects of mesenchymal stem cells in skin wound healing.
    Li M; Xu J; Shi T; Yu H; Bi J; Chen G
    Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1115-1124. PubMed ID: 27557877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a Vimentin
    Cooper TT; Sherman SE; Bell GI; Ma J; Kuljanin M; Jose SE; Lajoie GA; Hess DA
    Stem Cells; 2020 May; 38(5):666-682. PubMed ID: 31904137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration.
    Konala VB; Mamidi MK; Bhonde R; Das AK; Pochampally R; Pal R
    Cytotherapy; 2016 Jan; 18(1):13-24. PubMed ID: 26631828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the current advances in the treatment of inflammatory diseases using mesenchymal stromal cell secretome.
    Joshi JM; Muttigi MS; Upadhya R; Seetharam RN
    Immunopharmacol Immunotoxicol; 2023 Dec; 45(4):497-507. PubMed ID: 36786742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xenogeneic Mesenchymal Stromal Cells Improve Wound Healing and Modulate the Immune Response in an Extensive Burn Model.
    Caliari-Oliveira C; Yaochite JN; Ramalho LN; Palma PV; Carlos D; Cunha Fde Q; De Souza DA; Frade MA; Covas DT; Malmegrim KC; Oliveira MC; Voltarelli JC
    Cell Transplant; 2016; 25(2):201-15. PubMed ID: 25955320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale secretome analyses unveil the superior immunosuppressive phenotype of umbilical cord stromal cells as compared to other adult mesenchymal stromal cells.
    Islam A; Urbarova I; Bruun JA; Martinez-Zubiaurre I
    Eur Cell Mater; 2019 Feb; 37():153-174. PubMed ID: 30785213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.